Skip to main content

Profiles

Dewpoint Therapeutics

Dewpoint Therapeutics is an American biotechnology company based in Boston, Massachusetts.

COVID-19

Dewpoint participated as an industry partner in the Accelerating COVID-19 Therapeutic Interventions and Vaccines (ACTIV) public-private partnership hosted by the Foundation for the National Institutes of Health.[1]

Organization

Name Position Notes
Kara Carter Senior Vice President, Discovery Biology ACTIV Preclinical and TRACE Working Groups

Investors

Investors in Dewpoint Therapeutics include:[2][3][4]

  • 3E Bioventures Capital
  • 6 Dimensions Capital
  • Alexandria Venture Investments
  • ARCH Venture Partners
  • Bellco Capital
  • EcoR1 Capital
  • General Catalyst[5]
  • Innovation Endeavors
  • Leaps by Bayer
  • Maverick Ventures
  • Mirae Asset Capital
  • Mubadala Ventures
  • NS Investment
  • Polaris Partners
  • Samsara BioCapital
  • SoftBank Vision Fund[6]

Partners

Dewpoint is developing products through partnerships with:[7]

  1. ACTIV. National Institutes of Health (NIH). Retrieved April 1, 2022, from http://archive.today/2022.01.11-042823/https://www.nih.gov/research-training/medical-research-initiatives/activ ↩︎

  2. Series A - Dewpoint Therapeutics - 2019-01-30 - Crunchbase Funding Round Profile. Crunchbase. Retrieved July 3, 2023, from https://www.crunchbase.com/funding_round/dewpoint-therapeutics-series-a--aac46ca0 ↩︎

  3. Series B - Dewpoint Therapeutics - 2020-09-29 - Crunchbase Funding Round Profile. Crunchbase. Retrieved July 3, 2023, from https://www.crunchbase.com/funding_round/dewpoint-therapeutics-series-b--80fadead ↩︎

  4. Bressi, J., & Peterson, S. (2022, February 3). Dewpoint Therapeutics Announces Completion of $150 Million Series C Financing. Dewpoint Therapeutics. https://web.archive.org/web/20230703183902/https://dewpointx.com/dewpoint-therapeutics-announces-completion-of-150-million-series-c-financing/ ↩︎

  5. All Companies. (2022, October 28). General Catalyst. http://archive.today/2022.12.03-033447/https://www.generalcatalyst.com/list ↩︎

  6. Portfolio. SoftBank Vision Fund. Retrieved May 5, 2023, from https://web.archive.org/web/20230505171511/https://visionfund.com/portfolio ↩︎

  7. Pipeline. Dewpoint Therapeutics. Retrieved July 3, 2023, from http://archive.today/2023.07.03-184111/https://dewpointx.com/pipeline/%23partnerships ↩︎